Hip surgery adverse event reports that record this term

Kind of term: MedDRA preferred term

What a report is

A report is not proof that the drug was the cause of the event.

FDA says:

Adverse event reports submitted to FDA do not undergo extensive validation or verification. Therefore, a causal relationship cannot be established between product and reactions listed in a report. While a suspected relationship may exist, it is not medically validated and should not be the sole source of information for clinical decision making or other assumptions about the safety or efficacy of a product. Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview, section "Responsible use of the data". The site read the page on 2 Oct 2026. The data have the reports that FDA received through 30 Jun 2026.

FDA also says:

There is no certainty that the reported event (adverse event or medication error) was actually due to the product. FDA does not require that a causal relationship between a product and event be proven, and reports do not always contain enough detail to properly evaluate an event. The information in these reports has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of these events.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated.
Source: openFDA, Response of the drug event API (meta.disclaimer). The site read the page on 2 Oct 2026.

Not medical advice. This site counts what was reported to FDA. Questions about a medicine or device belong with a pharmacist or clinician.

Reports on file

From January 2004 to June 2026, FDA received 5,247 adverse event reports that record the MedDRA preferred term Hip surgery. The person who codes a report selects the term that agrees best with the description of the reporter.

FDA received 513 reports in the 12 months to June 2026 and 488 in the 12 months before. FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

By reports in the 12 months to June 2026, this term was number 977 of 1,436 reaction terms with a page. Of the 1,332,454 drug reports that FDA received in the 12 months to June 2026, 513 (under 0.1%) record this term. Reports for female patients were 64% of the reports that record this term and 52.7% of all drug reports.

The number of people who use the product is not in the data. A count is not a rate.

MedDRA

The Medical Dictionary for Regulatory Activities. The person who codes a report selects the preferred term that agrees best with the description of the reporter. FDA does not publish the description.

Data version

openFDA FAERS release of 29 Oct 2026. Reports received through 30 Jun 2026.

Drugs in these reports

The table has the 150 drug pages with 5 or more reports that record this term. The rows are in order of name. A drug page with fewer reports for this term is not in the table. The counts are the counts that the site keeps for each reaction term, and a count can be lower than the count of FDA.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Drugs that the reports with the term Hip surgery name as a suspect product, in order of name
Drug	Class	Reports with this term
Abatacept	Selective T cell costimulation modulator	42
Abrilada		5
Aclasta		18
Actemra	Interleukin-6 receptor antagonist	15
Adalimumab	Tumor necrosis factor blocker	17
Advair Diskus	Corticosteroid	24
Advair Hfa	Corticosteroid	16
Albuterol sulfate	beta2-Adrenergic agonist	6
Aldurazyme	Hydrolytic lysosomal glycosaminoglycan-specific enzyme	11
Alendronate sodium	Bisphosphonate	24
Ambrisentan	Endothelin receptor antagonist	18
Amlodipine	Calcium channel blocker	5
Amvuttra	Small interfering RNA	6
Aranesp	Erythropoiesis-stimulating agent	7
Arava	Antirheumatic agent	29
Aspirin	Nonsteroidal anti-inflammatory drug	7
Atripla		7
Aubagio	Pyrimidine synthesis inhibitor	12
Avonex	Interferon beta	44
Benlysta	B lymphocyte stimulator-specific inhibitor	12
Bimzelx		7
Breo Ellipta	Corticosteroid	13
Carbidopa levodopa	Aromatic amino acid	39
Celebrex	Nonsteroidal anti-inflammatory drug	16
Celecoxib	Nonsteroidal anti-inflammatory drug	11
Certolizumab pegol	Tumor necrosis factor blocker	70
Ciclosporin		11
Cimzia	Tumor necrosis factor blocker	44
Clozapine	Atypical antipsychotic	5
Copaxone		9
Corticotropin		8
Cosentyx	Interleukin-17A antagonist	20
Coumadin		5
Creon		15
Cyclosporine	Calcineurin inhibitor immunosuppressant	10
Dilaudid	Opioid agonist	23
Diovan HCT	Angiotensin 2 receptor blocker	8
Duodopa		26
Dupilumab	Interleukin-4 receptor alpha antagonist	6
Dupixent	Interleukin-4 receptor alpha antagonist	105
Eligard	Gonadotropin releasing hormone receptor agonist	6
Eliquis	Factor Xa inhibitor	16
Enbrel	Tumor necrosis factor blocker	413
Epidiolex		9
Erelzi		5
Etanercept	Tumor necrosis factor blocker	10
Evenity		12
Exelon	Cholinesterase inhibitor	8
Exjade	Iron chelator	10
Forteo	Parathyroid hormone analog	114
Fosamax	Bisphosphonate	45
Fosamax Plus D		5
Foscarbidopa/foslevodopa		10
Gold	Standardized chemical allergen	13
Humira		410
Hydrocodone bitartrate	Opioid agonist	5
Hydrocodone bitartrate and acetaminophen	Opioid agonist	15
Hydroxychloroquine sulfate	Antimalarial	9
Hyrimoz	Tumor necrosis factor blocker	9
Ibrance	Kinase inhibitor	48
Imbruvica	Kinase inhibitor	80
Inflectra	Tumor necrosis factor blocker	32
Infliximab	Tumor necrosis factor blocker	31
Ingrezza	Vesicular monoamine transporter 2 inhibitor	7
Inlyta	Kinase inhibitor	6
Januvia	Dipeptidyl peptidase 4 inhibitor	5
Jardiance	Sodium-Glucose cotransporter 2 inhibitor	8
Kevzara	Interleukin-6 receptor antagonist	7
Lacosamide		8
Lantus	Insulin analog	7
Lantus Solostar	Insulin analog	16
Lenalidomide	Thalidomide analog	7
Letairis	Endothelin receptor antagonist	15
Levemir	Insulin analog	5
Linzess	Guanylate Cyclase-C agonist	5
Lipitor	HMG-CoA reductase inhibitor	12
Lorazepam	Benzodiazepine	11
Lupkynis	Calcineurin inhibitor immunosuppressant	5
Lupron Depot		6
Lyrica		6
Meloxicam	Nonsteroidal anti-inflammatory drug	5
Mepolizumab	Interleukin-5 antagonist	22
Methotrexate	Folate analog metabolic inhibitor	81
Methotrexate sodium	Folate analog metabolic inhibitor	13
Minocycline	Tetracycline-class drug	6
Morphine	Opioid agonist	10
Morphine sulfate	Opioid agonist	16
MS Contin	Opioid agonist	5
Naglazyme	Hydrolytic lysosomal glycosaminoglycan-specific enzyme	12
Nexium	Proton pump inhibitor	6
Northera		5
Nucala	Interleukin-5 antagonist	10
Nuplazid	Atypical antipsychotic	48
Ocaliva		10
Ofev	Kinase inhibitor	15
Opsumit	Endothelin receptor antagonist	41
Orencia	Selective T cell costimulation modulator	43
Orgovyx	Gonadotropin releasing hormone receptor antagonist	10
Otezla	Phosphodiesterase 4 inhibitor	29
Oxbryta		19
Oxycodone and acetaminophen	Opioid agonist	13
Oxycodone hydrochloride	Opioid agonist	37
OxyContin	Opioid agonist	26
Ozempic	GLP-1 receptor agonist	29
Plaquenil	Antimalarial	21
Pradaxa	Direct thrombin inhibitor	6
Praluent	PCSK9 inhibitor	8
Prednisone	Corticosteroid	13
Prolia	RANK ligand inhibitor	89
Ranolazine		14
Remicade	Tumor necrosis factor blocker	84
Repatha	PCSK9 inhibitor	28
Revlimid	Thalidomide analog	10
Rinvoq	Janus kinase inhibitor	310
Rituximab	CD20-directed cytolytic antibody	9
Rotigotine	Nonergot dopamine agonist	16
Ruxience	CD20-directed cytolytic antibody	7
Simponi	Tumor necrosis factor blocker	56
Skyrizi	Interleukin-23 antagonist	236
Spravato		20
Stelara	Interleukin-12 antagonist	31
Stribild	Cytochrome P450 3A inhibitor	7
Sulfasalazine	Aminosalicylate	36
Tecfidera		30
Tolvaptan	Vasopressin V2 receptor antagonist	5
Tracleer	Endothelin receptor antagonist	47
Tramadol		8
Tramadol hydrochloride	Opioid agonist	5
Trelegy Ellipta	Anticholinergic	12
Tremfya	Interleukin-23 antagonist	20
Truvada	Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor	16
Tymlos		5
Tysabri	Integrin receptor antagonist	35
Uptravi	Prostacyclin receptor agonist	13
Vedolizumab	Integrin receptor antagonist	24
Venclexta	BCL-2 inhibitor	11
Ventolin Hfa	beta2-Adrenergic agonist	10
Vesicare		6
Vimizim	Hydrolytic lysosomal glycosaminoglycan-specific enzyme	49
Vioxx		6
Viread	Hepatitis B virus nucleoside analog reverse transcriptase inhibitor	8
Vivitrol		5
Votrient	Kinase inhibitor	9
Wegovy	GLP-1 receptor agonist	9
Xarelto	Factor Xa inhibitor	48
Xeljanz	Janus kinase inhibitor	178
Xyrem	Central nervous system depressant	69
Xywav	Central nervous system depressant	12
Zoledronic acid	Bisphosphonate	8
Zometa		12

The page of each drug has the count of each reaction term in its reaction lookup.

Drug classes in these reports

The table has the 52 pharmacologic classes with 10 or more reports that record this term. The rows are in order of name.

FDA says:

Additionally, it is important to remember that adverse event reports represent a small percentage of total usage numbers of a product. Common products may have a higher number of adverse events due to the higher total number of people using the product.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

Importantly, the AEMS data by themselves are not an indicator of the safety profile of the drug or biologic.
Source: FDA, FDA Adverse Event Monitoring System (AEMS) Public Dashboard. Content current as of 11 Mar 2026. The site read the page on 2 Oct 2026.

Pharmacologic classes of the drugs that the reports with the term Hip surgery name, in order of name
Class	Reports with this term
Aminosalicylate	36
Angiotensin 2 receptor blocker	14
Anticholinergic	14
Antimalarial	30
Antirheumatic agent	29
Aromatic amino acid	47
Atypical antipsychotic	62
B lymphocyte stimulator-specific inhibitor	15
BCL-2 inhibitor	11
Benzodiazepine	15
beta2-Adrenergic agonist	16
Bisphosphonate	77
Calcineurin inhibitor immunosuppressant	19
CD20-directed cytolytic antibody	18
Central nervous system depressant	83
Corticosteroid	77
Endothelin receptor antagonist	123
Factor Xa inhibitor	70
Folate analog metabolic inhibitor	96
GLP-1 receptor agonist	42
Gonadotropin releasing hormone receptor antagonist	10
Hepatitis B virus nucleoside analog reverse transcriptase inhibitor	12
HMG-CoA reductase inhibitor	14
Human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor	19
Human immunoglobulin G	10
Hydrolytic lysosomal glycosaminoglycan-specific enzyme	72
Insulin analog	44
Integrin receptor antagonist	59
Interferon beta	48
Interleukin-12 antagonist	33
Interleukin-17A antagonist	24
Interleukin-23 antagonist	256
Interleukin-4 receptor alpha antagonist	111
Interleukin-5 antagonist	32
Interleukin-6 receptor antagonist	22
Iron chelator	10
Janus kinase inhibitor	495
Kinase inhibitor	171
Nonergot dopamine agonist	16
Nonsteroidal anti-inflammatory drug	45
Opioid agonist	175
Parathyroid hormone analog	116
PCSK9 inhibitor	36
Phosphodiesterase 4 inhibitor	29
Prostacyclin receptor agonist	13
Proton pump inhibitor	14
Pyrimidine synthesis inhibitor	15
RANK ligand inhibitor	89
Selective T cell costimulation modulator	85
Standardized chemical allergen	13
Thalidomide analog	17
Tumor necrosis factor blocker	766

A class with many reports in all has many reports for almost every term.

Reports by month

Reports that record Hip surgery, by month, five years to June 2026

FDA releases FAERS data every quarter, so the newest months are not complete. They grow in later releases.

Patients in these reports

Age of the patient in the reports that record Hip surgery
Age	Reports	Share
Under 2	2	under 0.1%
2 to 11	64	1.2%
12 to 17	27	0.5%
18 to 44	293	5.6%
45 to 64	1,087	20.7%
65 to 74	908	17.3%
75 and over	784	14.9%
Age not given	2,082	39.7%

Sex of the patient in the reports that record Hip surgery
Sex	Reports	Share
Female	3,357	64%
Male	1,523	29%
Unknown or not given	367	7%

Age and sex are as the report gives them. 70.7% of these reports give the United States as the country.

Terms near this one

These are the next terms in the A to Z list. The links are for navigation.

Official pages

MedWatch Online Voluntary Reporting FormThe online form of FDA for a voluntary report.
MedWatch: The FDA Safety Information and Adverse Event Reporting ProgramThe page of the FDA program that receives reports about drugs and devices.
FDA Adverse Event Monitoring System (AEMS) Public DashboardThe public dashboard of FDA for adverse event reports on drugs and biologics.

The site checked these addresses on 2 Oct 2026. The links open in a new tab.

Cite this page

Reported Reactions. Hip surgery: adverse event reports that record this term. https://reportedreactions.com/reaction/hip-surgery/ Source: U.S. Food and Drug Administration, openFDA Drug Adverse Event (FAERS) files, release of 29 Oct 2026. Reports received through 30 Jun 2026.

Where the data come from

The counts come from the openFDA Drug Adverse Event (FAERS) bulk files, release of 29 Oct 2026. The files have the reports that FDA received through 30 Jun 2026. A drug name is the name on the report. The site matches it to a brand name or a generic name of the National Drug Code Directory of 2 Nov 2026. A class is the pharmacologic class (EPC) of the FDA label.

The count has the reports with each spelling of one MedDRA preferred term. The site does not publish a report narrative, a lot number, a detail of a patient or the identity of a reporter. The record of FDA is the authority. See how the site counts reports, the data sources and the corrections page.

Questions

What does Hip surgery mean in an adverse event report?

It is a MedDRA preferred term. FDA codes the description of a reporter with the MedDRA dictionary. The openFDA files do not have the description itself, and this site does not show it.

Does a drug in the table mean that the drug was responsible for this reaction?

No. FDA says:

No individual drug is connected to any individual reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

When a report lists multiple drugs and multiple reactions, there is no way to conclude from the data therein that a given drug is responsible for a given reaction.
Source: openFDA, Drug Adverse Event Overview. The site read the page on 2 Oct 2026.

What does this page tell a person who has this symptom?

This page gives counts of reports. It cannot assess a person. A pharmacist or a clinician can assess a person.

If this is a medical emergency, please call 911.
Source: FDA, MedWatch Online Voluntary Reporting Form. The site read the page on 2 Oct 2026.

To the top of the page